Media playback is unsupported on your device

Breast cancer drug deemed too expensive for use in England

8 August 2014 Last updated at 19:02 BST

The NHS drugs watchdog in England has rejected a treatment that can extend the lives of some women with an advanced form of breast cancer because it is too expensive.

The drug, Kadcyla, costs around £90,000 per patient.

Its makers, Roche, have offered a discount but the National Institute of Health and Care Excellence (NICE) said the new price - which is not being disclosed - made little difference.

Hugh Pym reports.

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.